Tomas Jovaisa

Dr. Tomas Jovaisa

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 December 2018 in Perfusion
Verified
Journal Article
Open access
PDF file
INIeva Norkiene
Ieva Norkiene
TJTomas Jovaisa
Tomas Jovaisa
NSNadiezda Scupakova
Nadiezda Scupakova
VJVilius Janušauskas
Vilius Janušauskas
KRKestutis Rucinskas
Kestutis Rucinskas
Robertas Stasys SamalavičiusRobertas Stasys Samalavičius
Robertas Stasys Samalavičius
Objective: The aim of our study was to explore long-term health-related quality of life (HRQOL) and incidence of post-traumatic stress disorder (PTSD) in extracorporeal membrane oxygenation (ECMO) survivors. Methods: Single-center prospective follow-up study. All patients in whom ECMO was initiated due to refractory cardiogenic shock between 2009 and 2014 were included in the study. We used Medical Outcomes Study 36-Item Short-Form Health Survey to evaluate HRQOL and IES-R questionnaire to assess incidence of PTSD. Results: Sixty-nine patients were treated with venoarterial (VA) ECMO during the study period. Nineteen patients survived until hospital discharge and 15 patients were alive at the study cut-off point in June 2017; mean follow-up time was 70.6 ± 10 months. The average Physical Component Summary and Mental Component Summary scores amongst long-term survivors were 46.1 ± 7 and 47.1 ± 8, respectively. PTSD was evident in 4 out of 15 participants. Conclusions: Despite the complex clinical course and prolonged recovery, ECMO survivors achieved satisfactory levels of both mental and physical recovery, which were comparable to the age- and pathology-adjusted population means.

25 October 2024 in Nutrition
Verified
Journal Article
Closed access
GSGintare Sostakaite
Gintare Sostakaite
MJMartyna Jauniškytė
Martyna Jauniškytė
DBDominykas Budrys
Dominykas Budrys
KBKastytis Budrevičius
Kastytis Budrevičius
ESErika Salciute-Simene
Erika Salciute-Simene
JŠJūratė Šipylaitė
Jūratė Šipylaitė

21 June 2024 in Acta Anaesthesiologica Scandinavica
Verified
Journal Article
Open access
PSPraleene Sivapalan
Praleene Sivapalan
KEKaren Louise Ellekjaer
Karen Louise Ellekjaer
APAnders Perner
Anders Perner
MMMorten Hylander Møller
Morten Hylander Møller
AGAnders Granholm
Anders Granholm
NINational investigators (NI) and site investigators
National investigators (NI) and site investigators
Introduction: Use of albumin is suggested for some patients with shock, but preferences for its use may vary among intensive care unit (ICU) physicians.Methods: We conducted an international online survey of ICU physicians with 20 questions about their use of albumin and their opinion towards a randomised trial among adults with shock comparing the use versus no use of albumin.Results: A total of 1248 respondents participated, with a mean response rate of 37%, ranging from 18% to 75% across 21 countries. Respondents mainly worked in mixed ICUs and 92% were specialists in intensive care medicine. The reported use of albumin in general shock varied as 18% reported ‘almost never’, 22% ‘rarely’, 34% ‘occasionally’, 22% ‘frequently’ and 4% ‘almost always’ using albumin. In septic shock, 19% reported ‘almost never’, 22% ‘rarely’, 29% ‘occasionally’, 22% ‘frequently’ and 7% ‘almost always’ using albumin. Physicians’ preferences were more consistent for haemorrhagic‐ and cardiogenic shock, with more than 45% reporting ‘almost never’ using albumin. While the reported use of albumin for other purposes than resuscitation was infrequent (40%–85% reported ‘almost never’ for five other indications), the most frequent other indications were low serum albumin levels and improvement of the efficacy of diuretics. Most respondents (93%) would randomise adult ICU patients with shock to a trial of albumin versus no albumin.Conclusions: In this international survey, the reported preferences for the use of albumin in adult ICU patients with shock varied considerably among surveyed ICU physicians. The support for a future randomised trial was high.

1 January 2025 in Computational and Structural Biotechnology Journal
Verified
Journal Article
Open access
AAAudrius Andrijauskas
Audrius Andrijauskas
PAPovilas Andrijauskas
Povilas Andrijauskas
DDDarius Dilijonas
Darius Dilijonas
IJIeva Jovaisiene
Ieva Jovaisiene
AVArūnas Valaika
Arūnas Valaika
TJTomas Jovaisa
Tomas Jovaisa
Summary: Purpose: This prospective observational clinical study investigated discrepancy between noninvasive continuous haemoglobin (SpHb, Masimo Corp., Irvine, CA) measurements with sensors placed on three fingertips during elective cardiac surgery. Materials and methods: The study included 12 adult patients who underwent elective coronary artery bypass grafting (CABG) under cardiopulmonary bypass (CPB). Three identical versions of SpHb sensors were placed on the fingers of the same hand and connected to dedicated Masimo Radical-7 monitors. Data were continuously recorded throughout the surgery. Multiple group comparison tests—Kruskal Wallis and Alexander Govern tests—were used to compare three sets of SpHb data (trends). Bland Altman and Giavarina plots were used to compare the SpHb data with invasive arterial haemoglobin (Lab-Hb) data obtained at clinically relevant time points chosen at the discretion of the cardiac anaesthesiologist, who was blinded to the study protocol. Results: There was a good correlation between the time-matched SpHb data from the three sensors at 253 time points (r = 0.86–0.95), but there was a significant difference between the SpHb values obtained from each sensor and the average SpHb value of all 3 sensors (p < 0.05) at each time point. The absolute difference between the SpHb value obtained from each sensor and the average SpHb value was 0.69 g/dl g/dl (SD 1.49 g/dl). The accuracy and precision of the average SpHb for estimating Lab-Hb was higher compared to the SpHb values obtained from two out of three individual sensors (sn1 and sn3) and very similar compared to values obtained from sensor sn2. Conclusion: The sensor placement site can impact the SpHb measurement causing discrepancy between SpHb measured in different fingers. The average SpHb from three fingertips appears to be more accurate and precise in estimating Lab-Hb. However, more advanced sensors are needed.

21 June 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
GSGintare Sostakaite
Gintare Sostakaite
MJMartyna Jauniškytė
Martyna Jauniškytė
DBDominykas Budrys
Dominykas Budrys
KBKastytis Budrevičius
Kastytis Budrevičius
ESErika Salciute-Simene
Erika Salciute-Simene
JŠJūratė Šipylaitė
Jūratė Šipylaitė
Background: Critically ill patients experience rapid muscle wasting during their ICU stay. Ultrasound (US) and bioelectrical impedance analysis (BIA) are widely used to assess muscle mass; however, their accuracy may be affected by fluid balance alterations. This study aimed to compare the reliability of US and BIA in detecting muscle loss under varying fluid balance conditions in ICU patients. Methods: In this prospective observational study, adult ICU patients with an ICU stay of ≥7 days were evaluated on Days 1, 5, and 7. Muscle thickness was measured using US, and phase angle (PhA) using BIA. Cumulative fluid balance, C-reactive protein (CRP), and lactate levels were recorded. Patients were stratified according to cumulative fluid balance. Results: A total of 143 ICU patients were included in the final analysis. US demonstrated a progressive decrease in muscle thickness (−3.54% ± 10.90% from Day 1 to Day 5 and −7.56% ± 11.82% from Day 1 to Day 7 (both p < 0.0001)), whereas BIA showed no significant change in PhA. Positive fluid balance significantly reduced PhA compared with the negative balance group, p < 0.001, whereas no statistically significant effect on US measurements was detected. CRP > 200 mg/L was associated with greater US-detected muscle loss on Day 5, while lactate > 2.5 mmol/L was associated with lower PhA. Conclusions: Ultrasound reliably identified structural muscle wasting in critically ill patients, with no statistically significant effect of fluid balance detected in this cohort. Furthermore, ultrasound measurements were associated with inflammation-related muscle loss. In contrast, BIA was strongly influenced by hydration and perfusion status, limiting its ability to assess true muscle mass loss in the ICU setting.

2 September 2026 in JMIR Formative Research
Verified
Journal Article
Open access
ADAustėja Dapkutė
Austėja Dapkutė
ONOlegas Niakšu
Olegas Niakšu
JJJulius Juodakis
Julius Juodakis
DJDanguolė Jankauskienė
Danguolė Jankauskienė
JTJustas Trinkunas
Justas Trinkunas
Rytis MasiliūnasRytis Masiliūnas
Rytis Masiliūnas
Background: National digital health systems are increasingly recognized as a key tool for strengthening health care systems and improving patient outcomes. Global guidance from the World Health Organization and European Union initiatives emphasizes interoperability, robust data governance, and secure exchange of health information as prerequisites for system-wide benefits. However, translating these principles into operational national digital health infrastructures remains challenging, and empirical evidence on long-term, centralized implementation models is limited. Lithuania is among a small number of European countries that have implemented a fully centralized national digital health platform (DHP), providing a valuable case for examining the development, structure, and performance of such systems. Objective: This study aimed to describe and analyze Lithuania’s national digital health system across its historical development, governance, technical architecture, interoperability and adoption, and to identify challenges and lessons learned. Methods: We conducted a descriptive national case study of Lithuania’s digital health system using longitudinal document analysis. Publicly available policy documents, legislation, strategy reports, audits, and official statistics published between 2000 and 2025 were systematically reviewed following the readying, extracting, analyzing, and distilling (READ) framework. Thematic analysis was applied to examine governance, system architecture, interoperability, adoption, and implementation challenges. Peer-reviewed literature was used for contextualization. Results: Lithuania’s digital health system evolved from fragmented initiatives in the early 2000s into a fully centralized national DHP that has been operational nationwide since 2015. Since 2018, health care providers have been required to record core clinical data electronically, and all reimbursed medicines are prescribed exclusively through the national electronic prescription system. The DHP integrates electronic health records, electronic prescription system, appointment booking, and other national subsystems with standardized interfaces. System use expanded rapidly: the annual number of electronic documents stored in the DHP increased from approximately 7 million in 2017 to over 100 million in 2024, reflecting widespread uptake of outpatient documentation, referrals, and prescriptions. Patient-facing services, including online access to records and a nationwide appointment booking system, also expanded, although patient-initiated use remains uneven across regions. The platform supports secure primary use for care delivery and secondary use of health data through a centralized access pathway. While core services have reached national scale, some subsystems, such as imaging exchange and telemedicine, remain less mature. Ongoing modernization focuses on improving data interoperability, enabling advanced analytics and future AI-based services, strengthening cross-border eHealth services, and extending coverage to sensitive and previously excluded domains such as mental health, maternal, and newborn care through dedicated subsystems. Conclusions: Lithuania’s centralized digital health system illustrates both the potential and the limitations of national-scale integration driven by legal mandates and standardized interoperability. Its experience provides transferable insights for health systems seeking to consolidate fragmented infrastructures while maintaining data security, regulatory compliance, and long-term system adaptability.